University of Southern California
USC Norris Comprehensive Cancer Center
If you are a patient, please contact Keck Medical Center of USC at 800-USC-CARE.

Trial 3C-13-1

A Phase III Double-blinded, Placebo Controlled Study of XilonixTM for Improving Survival in Metastatic Colorectal Cancer.

Type: Treatment
Phase: Phase III
Status: Open to Accrual
Treatments: Immunotherapy
Randomized: Yes
Defintions of terms and FAQ about clinical trials.
Trial Leaders/Researchers:  Afsaneh Barzi, M.D.
Other Trial Staff:  Ramona Lujan, R.N., Raluca Agafitei, Coordinator, Marile Garcia, Coordinator, Melissa Wallman, Coordinator, Noureddine Miloud, D.M., Rabia Rehman, Coordinator, Judy Lam-Tran, D.M.

Staff may log in to see study documents.

Click here to see trial eligibility criteria and further details at

For further information on a study, please contact the Clinical Investigation Support Office at (323) 865-0451, or

To schedule a consultation with the hospital, please call our New Patient Referrals Office at (323) 865-3111.